Summary:
- This article discusses a San Diego-based startup company called Ultima Genomics that is challenging the dominance of the gene sequencing giant Illumina in the field of DNA sequencing technology.
- Ultima Genomics has developed a new DNA sequencing platform that is significantly less expensive and faster than Illumina's technology, which has been the industry standard for over a decade.
- The article highlights the potential impact of Ultima Genomics' innovation on the field of genomics, as it could make DNA sequencing more accessible and affordable for researchers, clinicians, and individuals, potentially leading to advancements in personalized medicine and our understanding of the human genome.